NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Effect of Ocrelizumab on Choroid Plexus Changes in Patients With PPMS

CompletedN/A

Sponsor: State University of New York at Buffalo

Conditions: Primary Progressive Multiple Sclerosis

Interventions: Ocrelizumab

Countries: United States

The goal of this non-interventional, observational study is to learn if cortical plexus enhancement in patients with primary progressive multiple sclerosis occurs in response to the autoimmune inflammatory process.

Eligibility overview

Sex: ALL

Age: 18 Years to 65 Years

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patient participating in the ORATORIO study
* MRI scans available at baseline
* Presence of T2-weighted image (WI) (FLAIR, T2/PD), and 3D T1-WI at baseline

Exclusion Criteria:

\- None

Locations (1)

Buffalo, New York, United States